"Where to from here? We are still working on Charcot 2 that is primarily focusing on EBV activity and are taking forward an anti-EBV drug into MS. Will the peripheral suppression of EBV activity have any impact on MS disease activity? We think this hypothesis needs to be tested."
"We would like to thank all the MSers who participated in this study, without your selfless contribution this study would never have happened. Also a big thank you to the staff who made this study happen; for those of us in the know it was not an easy ride. And a massive thanks to our donors who initially primed the Charcot project, MSD for funding the INSPIRE study, and for all of you who continue to support the Charcot Project. Are we disappointed with the results? Everybody would like to see positive results, but that is not the way science works. Negative results are as important, if not more important, than positive ones. We will continue to walk where others fear to tread; we owe it to you the MS community. "